Drug Middlemen Seek FTC Recusals Over Bias in Insulin Case (1)

CVS Health Corp., UnitedHealth Group Inc. and Cigna Group said members of the US Federal Trade Commission who voted to sue prescription drug middlemen should be barred from overseeing the case, alleging that they’re biased against the industry.

Three members of the commission who advanced the enforcement action “made repeated incorrect prejudgments” about businesses owned by CVS, according to a legal filing by the largest US pharmacy benefit manager. The companies filed separate motions citing extensive public statements from the FTC commissioners criticizing pharmacy benefit managers, or PBMs.

Their demand marks the latest clash between the antitrust agency and ...